Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - MEDICAL CONNECTIONS HOLDINGS, INC.Financial_Report.xls

 



 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

(Amendment No. 1)

 

(Mark One)
S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2012

 

OR

 

£ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                     to                    

 

Commission File No. 333-72376

 

MEDICAL CONNECTIONS HOLDINGS, INC.


(Exact name of registrant as specified in its charter)

 

  Florida   65-0920373
  (State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

 

4800 T Rex Avenue Suite 310

Boca Raton, Florida

  33431
  (Address of principal executive office)   (Zip Code)

 

Registrant’s telephone number, including area code: (561) 353-1110

 

Former name, former address and former fiscal year, if changed since last report.

 

Indicate by a check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.       Yes  £      No  £

 

(Explanatory Note: The registrant is a voluntary filer and is not subject to the filing requirements of the Securities Exchange Act of 1934. However, during the preceding 12 months, the registrant has filed all report that it would have been required to file by Section 13 or 15(d) of the Securities Exchange Act of 1934 if the registrant was subject to the filing.)

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes S       No £ 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer £ Accelerated filer £
  Non-accelerated filer £ Smaller reporting company S
  (Do not check if smaller reporting company)      

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)     Yes  S       No  £ 

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock as of the latest practicable date:

 

24,500,678 shares of Common Stock, $.001 par value as of August 29, 2012

 



 
 

 

EXPLANATORY NOTE

 

The sole purpose of this Amendment No. 1 to Medical Connection Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012, filed with the Securities and Exchange Commission on August 14, 2012 (the “Form 10-Q”), is to furnish as exhibits to the Form 10-Q, pursuant to Rule 405 of Regulation S-T promulgated by the Securities and Exchange Commission, the consolidated financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).

 

No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the Form 10-Q.

 

Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

 

 
 

ITEM 6.   EXHIBITS
     
(3)   Exhibits.

 

  3.1.1 Designation of Series C Preferred Stock filed with the Florida Secretary of State on April 20, 2012 (1)
  31.1 Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (1)
  31.2 Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (1)
  32.1 Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)
  32.2 Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)
  101.INS XBRL Instance Document (2)
  101.SCH XBRL Taxonomy Extension Schema Document (2)
  101.CAL XBRL Taxonomy Extension Calculation Linkbase Document (2)
  101.DEF XBRL Taxonomy Extension Definition Linkbase Document (2)
  101.LAB XBRL Taxonomy Extension Label Linkbase Document (2)
  101.PRE XBRL Taxonomy Extension Presentation Linkbase Document (2)
 

 

(1) Filed with Medical Connections Holdings, Inc. Quarterly Report on Form 10-Q filed on August 14, 2012 for the period ended June 30, 2012 and incorporated herein.
(2) Furnished herewith.

 

SIGNATURES

 

            Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized

 

  MEDICAL CONNECTIONS HOLDINGS, INC.
     
Date:  August 30, 2012 By: /s/ Anthony Nicolosi
    Anthony Nicolosi,
    President and Director

                                                              

         In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Date:  August 30, 2012 By: /s/ Anthony Nicolosi
    Anthony Nicolosi,
    President and Director
    (Principal Executive Officer)

  

Date:  August 30, 2012 By: /s/ Brian R. Neill
    Brian R. Neill,
    Chief Financial Officer
    (Principal Financial/Accounting Officer)